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Summary points
• Antimicrobial stewardship (AMS) strategies are widely implemented in single health-
care sectors and organisations; however, the extent and impact of integrated AMS initia-
tives across the whole health economy are unknown.
• Assessing degree of integration of AMS across the whole health economy and its impact
is essential if we are to achieve a ‘One Health’ approach to addressing antimicrobial
resistance (AMR), and therefore we searched systematically for and analysed published
examples of integrated AMS initiatives to address this gap.
• Application of a system-level framework to analyse integration of AMS initiatives across
and within healthcare sectors shows that integration is emerging but needs
strengthening.
• Findings from a small number of evaluations in high-income countries suggest that
antimicrobial prescribing and healthcare-associated infections can be reduced using a
multisectoral integrated AMS approach.
• More robust research designs to evaluate and understand the impact of multisectoral
integrated AMS are needed, particularly with respect to differing health systems in dif-
ferent countries and local organisational contexts.
• Our analysis highlights a number of challenges and ways forward for enhancing the
delivery of AMS through an integrated approach.
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Background
It is estimated that around 700,000 people die annually from drug-resistant infections, with
experts predicting an alarming possible increase to 10 million deaths each year by 2050 and
major future challenges to the way we practice medicine and surgery [1,2]. It was welcome
news that tackling antimicrobial resistance (AMR) and infectious diseases along with health
system strengthening were featured at the G20 summit (November, 2018), under the wider
aim of improving sustainability, and progress towards more coordinated international efforts
will be reviewed at the 73rd session of the UN General Assembly (September 2018) [3]; but
how are health professionals, managers, and policymakers assuring coordinated efforts within
human healthcare? Globally, there has been much emphasis on a ‘One Health’ approach that
involves connecting the health of humans, animals, and the environment to tackle AMR [2].
This is driving much-needed antimicrobial stewardship (AMS) activities in animal production
sectors [4]. However, we have yet to achieve and establish joined-up approaches within human
health. This paper, therefore, focuses on an analysis of multisectoral AMS in human health.
AMS remains a cornerstone for addressing AMR with numerous initiatives implemented with
varying degrees of success [5,6]. A critical gap we have identified is that approaches have
largely focused efforts separately in primary care or secondary care, and have also heavily tar-
geted medical prescribers. In this paper, we propose that policymakers, clinical leaders, and
healthcare managers assess and consolidate AMS activities across the whole health economy,
and we use a novel, to our knowledge, approach to demonstrate how such an assessment can
be made. We present the extent to which existing AMS initiatives are multisectoral or inte-
grated across a whole health economy within individual countries and their impact on antimi-
crobial-related outcomes. We then highlight some challenges and key considerations for
developing and harnessing potential benefits of integrated AMS approaches.
Need for a whole-health–economy approach
Health systems are required to deliver best outcomes efficiently, facing the challenges of mac-
roeconomic constraints, technology costs, and increasing public need and demand. Consoli-
dating the sometimes disparate programs and initiatives within the health sector is necessary,
and integrated models of care across primary, secondary, tertiary, and long-term care can help
with coordinated implementation of AMS [7]. Assessment of the degree of integration of AMS
across the whole health economy is essential if we are to understand how a ‘One Health’
approach to addressing AMR may be achieved. Much AMS activity has been concentrated in
hospital settings, creating a practical but somewhat artificial boundary that neglects bidirec-
tional influences between hospital and community care services. Antimicrobial use in the
community is associated with the development of AMR in and outside hospitals [8]. Further-
more, use of accident and emergency departments by ambulatory patients contributes to frag-
mented care and overuse of antimicrobials [9]. The way people access healthcare has evolved:
the availability of blended care and complex patient-care pathways in some countries allows
for patient-centred approaches as well as more rational use of services. The availability of anti-
microbials without a prescription in some countries and increasing availability of online phar-
macies provides an additional challenge for AMS. Fundamentally, AMS is lagging behind the
advances made in health service delivery and patient behaviours by remaining sector-based.
What does integration mean and how can we assess it?
The One Health perspective on integration involves multiple sectors communicating and
working together to design and implement programs, policies, legislation, and research to
achieve better public health outcomes [2]. In practice, in England, new integrated care models
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are being developed through 50 selected collaborative organisations that will inform potential
redesign of the whole health system, and 25 integrated care pioneer sites to test new and differ-
ent ways of joining up health and social care services [10]. Elsewhere in Europe, the Dutch
Ministry of Health, Welfare, and Sport established nine pioneer sites to integrate clinical and
community services with the aim of achieving ‘better healthcare at lower cost’ [11]. In the
United States, accountable care organisations—which typically involve multiple physician
practices and at least one hospital—have been established to improve the quality of care while
lowering costs [12]. However, AMS is not explicit in any of these wider health-system–integra-
tion models.
To further complicate matters, there is no standard definition of integration, and a number
of integrated care models have been proposed in the literature [13–17] (S1 Table). In this anal-
ysis, we define and summarise the extent of integration based on the six facets of critical health
system function described by Atun and colleagues [16,18] because it provides a practical level
of granularity on the concept of intervention integration and is specific to healthcare
(Table 1). We appreciate that there may be unpublished initiatives. However, as a novel, to our
knowledge, analysis of this issue, the focus was on examining evidence of integrated AMS ini-
tiatives from the literature so that some measures of impact and associated context can be
synthesised. Our aim was to identify practical considerations to support policymakers seeking
to develop integrated AMS across the whole health economy. We carried out a systematic
search of the literature published between January, 2006 and December, 2018, selected relevant
articles using prespecified inclusion criteria, and reviewed evaluative studies (S1 Appendix).
This paper describes an analysis based on 16 AMS initiatives from nine high-income countries
and one low-middle–income country (Tables 2 and 3).
Table 1. Critical health system functions and elements of integration adapted from Atun and colleagues [16,18]
for AMS initiatives.
Facets of Critical Health System Function Elements of Integration Adapted for AMS Initiatives
Stewardship and governance • Regulatory mechanism
• Accountability framework
Financing • Pooling of funds
• Provider payment methods
• Funding source
• Cross-program use of funds
Planning • Planning
Service delivery • Human resources for delivery of AMS
• Physical infrastructure for laboratory testing
Monitoring and evaluation • Data collection and recording
• Data analysis
• Reporting systems
• Performance management system
Demand generation • Financial incentives
• Information, education, and communication
Definition of full and partial integration: An element was classed as fully or predominantly integrated across the
health system if it was exclusively under the management and control of the wider healthcare system. An element was
classed as partially integrated if some but not all cases were managed and controlled both by the wider healthcare
system and a specific program-related structure. A dimension was not integrated if it was exclusively under the
management and control of a specific program-related structure (which is distinct from the wider healthcare system).
Abbreviations: AMS, antimicrobial stewardship.
https://doi.org/10.1371/journal.pmed.1002774.t001
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Table 2. Impact of 16 integrated AMS initiatives identified.
AMS Initiative Study Design/Type Reported Impact Limitations for Future Work
Australia
Infection control nurse consultant in
residential aged care facilities [19]
Uncontrolled before and
after study
Reduction in the use of cephalexin, doxycycline,
flucloxacillin, clindamycin, and metronidazole. Rates of
infection types remained stable, except respiratory tract
infection rates increased at one of the two study sites.
No control group
National multistrategic AMS program
for health professionals and the
community [20]
Uncontrolled before and
after study
Continued decline in total volume of antibiotics
prescribed, GPs and pharmacists perceived the
campaign assisted in AMS message promotion to
patients, improvement in consumer knowledge and
attitudes about self-management of infections
Possible impact of other national
level campaigns not known; no
control group
Canada
Northern Antibiotic Resistance
Partnership [21]
Cohort study Reduction in MRSA infection rate and an increase in
knowledge related to antimicrobial use and hand
washing in the community
No data knowledge (adults and
children) in nonintervention
communities
Do Bugs Need Drugs program [22] Uncontrolled interrupted
time series
Program improved clinical knowledge and rate of
appropriate antibiotic prescribing for upper respiratory
tract infections. Ecological association between
program implementation and stabilising of antibiotic
prescribing and costs.
No control group
Greece
A multifaceted campaign targeting both
physicians and parents of school children
on judicious use of antibiotics [23]
Uncontrolled before and
after study
Overall antibiotic consumption was unchanged;
however, the proportion of amoxicillin and
phenoxymethylpenicillin used increased compared
with a decrease in macrolides, cephalosporins, and
fluoroquinolones
Seasonal and other temporal
confounding factors not accounted
for
Italy
Toolkit for managing ESBL-E
colonisation and infection [24]
Uncontrolled before and
after study
Reduction in overall antibiotics prescribed from 60% of
patients with asymptomatic ESBL-E to 39%
No control group
Sweden
Strama [25] Uncontrolled time series
and institute publication
Reduction in outpatient antibiotic use, particularly in
children aged 5–14 years and for macrolides
No control group
United Kingdom
Enhanced AMS program in hospital and
community [26]; Northern Ireland
Interrupted time series Reduction in fluoroquinolone use and associated
reduction in MRSA incidence in the community
No control group
Scottish Antimicrobial Prescribing
Group [27]; Scotland
Descriptive study Contributed to the reduction of Clostridium difficile
infection rates, improved clinical management of
infections
Nonexperimental study design
The Cornwall One Health Antimicrobial
Resistance Group [28]
Descriptive study Attributed reductions in antibiotic consumption by
12.8% in total (before and post-group formed) to the
implementation of the TARGET toolkit (a national
AMS toolkit for general practice)
Nonexperimental study design
Mixed persuasive and restrictive
antibiotic stewardship intervention [29];
Scotland
Observational and
quasiexperimental time-
series analysis
Reducing population consumption of fiuoroquinolone,
cephalosporins, clindamycin, and macrolides predicted
large and sustained declines in C. difficile infection
prevalence in both hospitals and the community.
Associations with C. difficile infection occurred only
where use of these antibiotics exceeded total use
thresholds, consistent with the importance of selective
pressures favouring epidemic ribotypes.
Further multicentre time-series
analyses or cluster-randomised
controlled trials would strengthen
evidence
United States of America
The Core Elements of Antibiotic
Stewardship for Nursing Homes [30]
National guidance Not evaluated
A household- and office-based patient
educational intervention and physician-
centred intervention [31]
Controlled trial Reduction in antibiotic prescription rate post-patient
education and minor reduction in antibiotic
prescription rate post-physician intervention
Claims data may miss emergency
department data
(Continued)
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Extent of AMS integration across the whole health economy
Integration mapping of the 16 initiatives based on Table 1 suggests that a range of approaches
have been used to achieve multisectoral AMS (Fig 1). Full integration in Planning was often
considered a key factor for establishing many initiatives coupled with an integrated Steward-
ship and Governance approach. Integration in these two facets was mainly achieved through
expansion of the AMS program, by which the primary governance responsibilities remained
with the host institution [19,20,30,32,33], rather than through establishment of new structures
[25]. AMS initiatives that had a shared governance structure across healthcare organisations
(i.e., partially integrated) were either national programs [27] or state-wide programs [26,31].
While these provide examples of an integrated AMS governance approach, effective gover-
nance is likely to require much more than a multistakeholder approach to plan and deliver ser-
vices; a mixed regulatory and persuasive strategy including effective public engagement is
needed [38]. In our analysis, nine initiatives were partially integrated for Demand Generation,
showing a potential missed opportunity for this critical facet that includes raising awareness
and increasing engagement with the public, practitioners, health service managers, and policy-
makers. Monitoring and Evaluation relate to the functions around data collection, analysis,
reporting, and performance-management systems. Full integration was identified in one ini-
tiative in which the health system oversaw these functions regionally or was responsible for
these functions directly [33]. More often, data collection and analyses were managed by the
wider health system; however, performance management roles were not [19,20,22,25,26,32].
Financing relates to the pooling of funds/funding source, cross-program use of funds, and pro-
vider payment methods involved in the AMS initiative. The majority of initiatives did not
report on how they were or should be financed or how the funds were or should be used
[19,20,22,23,26,30,32]. While fund pooling was partially integrated in three initiatives
[25,32,33], decisions for provider payment methods were not. Overall, 11 studies evaluated the
AMS initiative using mainly quasiexperimental study designs [19–23,25,27,30,31,39] (S2
Table). These reported on a range of positive impacts including reductions in antibiotic pre-
scribing, reductions in the proportion of broad-spectrum antibiotic prescribed, reduction in
C. difficile infection rates, and perceived improvement in citizens’ knowledge and attitudes
about self-management of minor infections. However, potential for bias should be borne in
mind because of study limitations associated with uncontrolled research designs, insufficient
data time points, and risk of self-selection by participants who are interested in AMS.
Table 2. (Continued)
AMS Initiative Study Design/Type Reported Impact Limitations for Future Work
Extending hospital-pharmacist–led AMS
team services to hospital-affiliated
nursing home [32]
Uncontrolled before and
after study
Reduction in inappropriate antibiotic prescribing
Introduction of an LID consult team
(hospital infectious disease physician and
nurse practitioner) to a long-term care
facility [33]
Interrupted time-series
study and cohort study
Reduced antibiotic use, particularly with tetracyclines,
clindamycin sulfamethoxazole/trimethoprim,
fluoroquinolones, and beta-lactam/beta-lactamase
inhibitor combinations. Reduced positive C. difficile
test rate.
Total days of therapy measured (not
number of antimicrobial courses
initiated)
Zambia
BeatRHDZambia initiative[34] Uncontrolled before and
after study
Substantial changes in the pattern of benzathine
penicillin G usage as a result of the intervention was
reported but no data were presented
No control group
Abbreviations: AMS, antimicrobial stewardship; ESBL-E, extended-spectrum beta-lactamase producing Enterobacteriaceae; GP, general practitioner; LID, long-term
care facility infectious disease; MRSA, methicillin-resistant Staphylococcus aureus; TARGET, Treat Antibiotics Responsibly, Guidance, Education, Tools.
https://doi.org/10.1371/journal.pmed.1002774.t002
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Table 3. Stakeholders in the integrated AMS initiatives identified.
Study–AMS initiative AMS Initiative Developed and Implemented by Target Recipients for the AMS Initiative
Australia
Infection control nurse consultant in
residential aged care facilities [19]
GPs, infection control clinical nurse consultant, AMS team
in residential aged care facility, and off-site hospital
infectious disease physician
GPs in residential aged care facility
National multistrategic AMS program for
health professionals and the community [20]
National Prescribing Service GPs, community pharmacists, general public
Canada
Northern Antibiotic Resistance Partnership
[21]
University of Saskatchewan, Health Canada Research Ethics
Boards
Primary healthcare providers, general public, school
staff, and children
Do Bugs Need Drugs program [22] Alberta Health Services (spanning primary and secondary
care), Alberta Medical Association, University of Alberta,
Alberta Lung Association, British Columbia Ministry of
Health and British Columbia Centre for Disease Control.
Healthcare providers and healthcare and early childhood
education students were trained to deliver the public
education sessions.
Children aged 2–5 and 7 years, their parents, older adults
in assisted-living facilities, general public, community-
based physicians and pharmacists
Greece
A multifaceted campaign targeting both
physicians and parents of school children on
judicious use of antibiotics [23]
Medical school of the University of Athens, Prefecture of
Corinth, Medical Association of Corinth, physician who
specialised in infectious diseases
Primary care physicians, paediatricians, parents of
children in nursing care and primary school, general
public, dentists
Italy
Toolkit for managing ESBL-E colonisation
and infection [24]
An initiative led by a network of infectious diseases
specialists in Southeastern France developed a warning
system combined with a toolkit for managing ESBL-E
colonisation or infection in collaboration with
microbiologists from private laboratories and community-
based GPs. The toolkit promoting French
recommendations was implemented in Liguria, Italy
(because there were no national recommendations at the
time). This comprised a framework for establishing the
warning system based on the availability of infectious
diseases expert advice and the ESBL-E toolkit.
Prescribers in hospitals, elderly nursing homes, long-
term care facilities, GPs
Sweden
Strama [25] Strama groups were established through the County
Medical Officers for Communicable Diseases Control in
every county. Groups had representatives from general
practice and hospital (including general medicine,
infectious diseases, paediatrics, otolaryngology, clinical
microbiology, and infection control) and community
pharmacies.
Broad audience including policy makers, physicians, and
general public
United Kingdom
Enhanced AMS program in hospital and
community [26], Northern Ireland
General practice staff and hospital clinical staff Hospital clinical staff, GPs
Scottish Antimicrobial Prescribing Group
[27], Scotland
Hospital-based antimicrobial pharmacists, microbiologists,
infectious disease specialists, hospital medical and
nonmedical leadership, infection prevention specialists,
information/antimicrobial surveillance scientists, GPs,
dentistry, veterinary medicine, quality improvement,
pharmaceutical industry, other expert advisors
Broad audience including policy makers, physicians, and
general public
The Cornwall One Health Antimicrobial
Resistance Group [28]
Developed by a subgroup of the Health & Wellbeing Board’s
Health Protection Committee. The Chief Hospital
Pharmacist and Medical Director initiated wide stakeholder
engagement including members from wider hospital staff,
clinical commissioning group, community hospital, out-of-
hours GP service, dentistry, veterinary, and farming.
Broad audience including policy makers, physicians, and
general public across sectors
(Continued)
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Opportunities and implications for policy
Especially when planning new initiatives, a health system function framework as employed
here can be critical to minimise duplication of effort and achieve efficiencies from the view-
point of healthcare professionals and service users. Our assessment has highlighted strengths
of initiatives associated with beneficial outcomes, and we present these as three interconnected
practical recommendations for policymakers to consider.
A successful integrated AMS approach can be developed through
expansion of an existing AMS program
When compared to hospital-based AMS, strategies within primary care and long-term care
have generally been slow to develop. Outside of hospitals, structural constraints sometimes
include undefined AMS leadership at the organisational level and therefore unclear responsi-
bilities around local AMS objectives and lack of timely pathways to specialist support. An inte-
grated AMS model, particularly one involving secondary care, can overcome some of the
community-based issues by either extending existing secondary-care AMS programs
[19,26,32,33], adapting from established frameworks for secondary-care AMS [30], or creating
a joint platform for multisectoral AMS strategies to be presented, developed, monitored, and/
or shared [25,27]. It therefore follows that an integrated AMS program may also be able to
Table 3. (Continued)
Study–AMS initiative AMS Initiative Developed and Implemented by Target Recipients for the AMS Initiative
Mixed persuasive and restrictive antibiotic
stewardship intervention [29]; Scotland
Nationally developed but implemented by regional
antimicrobial management teams.
Healthcare professionals in primary care, tertiary
hospitals, district-general hospitals, and geriatric
hospitals
United States of America
The Core Elements of Antibiotic Stewardship
for Nursing Homes [30]
Consultant pharmacist (community and/or hospital) and
clinical and nursing staff
Nursing home staff
A household and office-based patient
educational intervention and physician-
centred intervention [31]
Colorado medical society and commercial and managed
care organisation
Primary care physicians
Extending hospital-pharmacist–led AMS
team services to hospital-affiliated nursing
home [32]
Hospital internal medicine physician, pharmacists, infection
control coordinator, and staff from nursing home
Prescribers in nursing home
LID consult team in a long-term care facility
[33]
Hospital infectious disease physician and nurse practitioner
and long-term care facility staff
Long-term care facility staff
Zambia
BeatRHDZambia initiative [34] Hospital microbiologists, infectious disease consultants,
pharmacists, nurses, pharmaceutical advisors, GPs,
academics, pharmaceutical advisors, representation from
veterinary and farm services, representation from
community pharmacy, Public Health England,
representation from dental practice, public health
educators, and public representation
General public, healthcare workers and vets, GPs,
community pharmacies, urgent care centre staff, staff,
and patients at the study hospital and government clinics
in Lusaka
AMS initiatives, models, programs, and interventions are terms that are used interchangeably in the literature. Here, we use ‘AMS model’ to refer to a proposed
simplified framework that outlines the structure, processes and intended outcomes associated with the goal of AMS [35]. Examples are the internationally recognised
AMS model for hospitals from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America [35,36] and British Society for
Antimicrobial Chemotherapy [37]. An AMS intervention is any action taken with the aim of improving antimicrobial use, e.g., use of delayed/back-up antibiotic
prescriptions or implementation of infection specialist approval for restricted antimicrobials. Accordingly, an AMS program describes a coordinated effort to improve
antimicrobial use that involves two or more AMS interventions. Abbreviations: AMS, antimicrobial stewardship; ESBL-E, extended-spectrum beta-lactamase producing
Enterobacteriaceae; GP, general practitioner; LID, long-term care facility infectious disease.
https://doi.org/10.1371/journal.pmed.1002774.t003
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address process issues such as fragmented and timely follow-up of patients, their symptom
progression, and medical management. However, further research is required to investigate
this. Critically, there is a need for establishing sustainable funding for AMS teams working
beyond hospital settings that is not solely derived from cost savings through reduced drug
expenditure. Instead, funding for developing and supporting AMS teams should be considered
within the patient safety and healthcare-quality–related spending [40]. Irrespective of these
issues, adoption and uptake of AMS strategies are likely to be influenced by the underlying
health system and culture in a country.
Opportunities for success establishing consistent communication channels
with responsibilities and common goals clearly defined
Few health systems appear to have effective mechanisms for sharing and disseminating learn-
ing about AMS, leading to small-scale local initiatives. Strengthening communication between
commissioners, providers, and consumers by having more structured and clear communica-
tion pathways, such as in the Strama model developed in Sweden and the similarly structured
Scottish Antimicrobial Prescribing Group, can be an effective way to develop, disseminate,
and monitor ways to improve AMS [25,27].
Capitalise on existing resources and processes
Patients and the public have a pivotal role in infection prevention and management, yet failure
to involve and engage with them in decision-making or achieve sustained behaviour change
remains a problem in all health sector settings [41,42]. We found few examples of patient or
public involvement in the design and delivery of integrated AMS initiatives (Table 3). How-
ever, we know from other studies that patient misconceptions about AMR and what consti-
tutes appropriate antibiotic use is a major driver for inappropriate behaviours around
antibiotic use [43]. Furthermore, our stakeholder analysis suggests that there are potentially
Fig 1. An overview of the extent of multisectoral AMS integration for each of the 16 AMS initiatives identified. The
integration framework is based on all six facets of critical health system function defined by Atun and colleagues [16,18]
(Table 1). AMS, antimicrobial stewardship.
https://doi.org/10.1371/journal.pmed.1002774.g001
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more opportunities for integration, particularly involving primary care service providers. For
instance, in the United Kingdom, it is well recognised that nurses and pharmacists in the com-
munity are generally more accessible to the public than general practitioners (GPs). The con-
tinuing expansion of their roles in the community, which not only provides support to
patients but also reduces the burden on primary care physicians, is testament to this [44,45].
However, there are few AMS initiatives that capitalise on these valuable resources to deliver
integrated AMS—by this, we mean appropriate antibiotic access and preservation and knowl-
edge mobilisation for promoting AMS that is aligned with primary, secondary, tertiary, and
long-term institutional care sectors. We found little involvement of dental practitioners in
most multisectoral AMS initiatives, which is another missed opportunity. Further work is
required to investigate such AMS roles in the community and embed these more widely as
applicable in the respective country. A more robust evidence base is needed to establish the
effectiveness of integrated AMS initiatives and specifically consider contextual antecedents to
better inform future sustained improvements.
Overall, we urge policymakers, clinical leaders, and healthcare managers to assess and con-
sider consolidating AMS activities across the whole health economy. Each of these stakehold-
ers have an important role to drive and support clinicians, researchers, and research-active
patients to carry out quality research that will inform the development of more robust evi-
dence-based policies and guidelines. The analytic framework presented here can be used to
assess the extent of integration of existing or planned multisectoral AMS initiatives, and we
have outlined three areas with practical considerations towards how future integration of AMS
initiatives across the whole health economy may be achieved. Ultimately, integrated AMS
must prove itself as an essential element of efficient redesign if it is to deliver sustained patient
benefits.
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